Evidence map›Paper›PMID 36571707›Full record

ReviewBreast cancer (Tokyo, Japan)2023

What do we know about treating breast-cancer-related lymphedema? Review of the current knowledge about therapeutic options.

Karolina Anuszkiewicz, Jerzy Jankau, Martyna Kur

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Breast cancer (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Karolina Anuszkiewicz *Department of Plastic Surgery, Faculty of Medicine, Medical University of Gdańsk, 80-214, Gdańsk, Poland. karolina.anuszkiewicz@gumed.edu.pl.ORCID http://orcid.org/0000-0003-2461-4720
Jerzy Jankau *Department of Plastic Surgery, Faculty of Medicine, Medical University of Gdańsk, 80-214, Gdańsk, Poland.ORCID http://orcid.org/0000-0002-2064-7616
Martyna KurDepartment of Plastic Surgery, Faculty of Medicine, Medical University of Gdańsk, 80-214, Gdańsk, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast-cancer-related lymphedema (BCRL) is a common consequence of oncological treatment. Its management is a complicated, chronic, and arduous process. Therapeutic options can be divided on non-surgical and surgical methods, although there is still no clear consensus about their effectiveness in preventing or stopping the disease. That brings problems in everyday practice, as there are no guidelines about proper time for starting therapy and no agreement about which management will be beneficial for each patient. The aim of this review is to summarize current knowledge about possible treatment choices, non-surgical so as surgical, indicate knowledge gaps, and try to direct pathways for future studies.

Indexed as

Breast Cancer LymphedemaBreast NeoplasmsLymphedemaFemaleHumansBreast cancerLymphedemaPreventionTreatment

Identifiers

PMID36571707
PMCPMC9950281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.